This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Altered Neural Pain Empathic Reactivity in NSSI Adolescents

Sponsored by University of Electronic Science and Technology of China

About this trial

Last updated 2 years ago

Study ID

BAM_lab_NSSI_02

Status

Recruiting

Type

Observational

Placebo

No

Accepting

15 to 18 Years
All Sexes

Trial Timing

Started 3 years ago

What is this trial about?

Nonsuicidal self-injury (NSSI) is defined as direct, deliberate bodily harm without suicidal intention. In recent years, growing evidence suggests that NSSI has become a worldwide public health issue. People with NSSI behaviors, especially adolescents, commonly exhibit emotion-related and interpersonal problems. Pain empathy represents an essential basal domain of socio-emotional processing and refers to the ability to empathize, connect and share with others' pain. However, altered empathic processing has not been systematically examined in adolescents with NSSI. To this end, the current functional magnetic resonance imaging (fMRI) study will recruit one group of NSSI adolescents (n=40) and one healthy control (HC) group (n=40), to compare their neural activity regarding pain empathy processing, which is measured by blood oxygenation level-dependent (BOLD) fMRI. The investigators included conditions of physical pain empathy (stimuli depicting noxious stimulation to the limbs) and affective pain empathy (stimuli depicting faces expressing pain) as well as corresponding control stimuli. The investigators hypothesize that compared to HC, NSSI adolescents show increased empathic reactivity to physical pain stimuli in salience and arousal related brain regions but decreased empathic reactivity to affective pain empathic stimuli.

What are the participation requirements?

Inclusion Criteria

* 15-18 years

* right-handed

* normal or corrected normal visual acuity

* meet the proposed DSM-5 frequency criteria (e.g., ≥5 days of NSSI behaviors in the past year)

Exclusion Criteria

* diagnosis of borderline personality disorder, major depressive disorder, other

* psychiatric disorders, etc.

* high suicidal risk

* recent use of medications that can affect neural activity

* have received or are receiving Dialectical Behavior Therapy (DBT) other treatment for emotional problems within the past 6 months

* have a contraindication to MRI scanning (e.g., metal implants, claustrophobia or other conditions that make them inappropriate for MRI scanning)